Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib

Published:2020-12 Issue:6 Volume:59 Page:102920
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Mori Shunsuke^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update;Smolen;Ann Rheum Dis,2020

2. Leukocytapheresis in rheumatoid arthritis;Hidaka;Transfus Apher Sci,2017

3. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate;Kempe;Ther Apher Dial,2004

4. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis;Onuma;Ther Apher Dial,2006

5. Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis;Eguchi;Mod Rheumatol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cartilage Defects and Diseases: Conventional Therapies and Its Limitations;Cartilage: From Biology to Biofabrication;2023

2. Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review;Clinical Rheumatology;2021-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP